All subjects | Probable bacterial | Probable viral | Undetermined | |
---|---|---|---|---|
n = 110 | n = 74 | n = 16 | n = 20 | |
Demographics and clinical presentation | ||||
Males (%) | 61 (55.4) | 45 (60.8)* | 5 (31.2)* | 11 (55.0) |
Mean age ± SD (years) | 4.8 ± 3.4 | 5.1 ± 3.4 | 3.6 ± 2.8 | 4.9 ± 3.5 |
Caucasians (%)a | 95 (88.8) | 62 (87.3) | 13 (81.2) | 20 (100.0) |
At least one parent smoked (%)a | 28 (25.9) | 19 (26.0) | 5 (31.2) | 4 (21.0) |
Presence of fever” (%) | 91 (82.7) | 64 (86.5) | 12 (75.0) | 15 (75.0) |
O2 therapy (%)a | 26 (25.2) | 14 (19.7)* | 7 (50.0)* | 5 (27.8) |
Clinical findings (%) | ||||
Rhonchi | 12 (10.9) | 5 (6.8) | 3 (18.7) | 4 (20.0) |
Rales | 92 (83.6) | 63 (85.1) | 14 (87.5) | 15 (75.0) |
Wheezing | 21 (19.1) | 11 (14.9) | 3 (18.7) | 7 (35.0) |
Any of the above | 96 (87.3) | 64 (86.5) | 15 (93.7) | 17 (85.0) |
Severe disease | 84 (76.4) | 59 (79.7) | 12 (75.0) | 13 (65.0) |
Laboratory data | ||||
WBC (cells/μL)a | 15,741 ± 8,575 | 16,573 ± 8,969 | 13,674 ± 7338 | 14,358 ± 7,899 |
Neutrophils, %a | 66.1 ± 19.3 | 68.3 ± 18.4 | 65.2 ± 17.8 | 59.2 ± 22.9 |
CRP, μg/dLa | 25.5 ± 47.4 | 32.2 ± 55.5* | 9.4 ± 17.0* | 14.0 ± 19.4 |
LIP2, ng/mL | 2,079 ± 1,606 | 2,158 ± 1,744 | 1,880 ± 1,015 | 1,946 ± 1,488 |
SYD4, ng/mL | 5.08 ± 3.95 | 5.27 ± 4.10 | 4.31 ± 3.06 | 4.99 ± 4.14 |